Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

Find a Doctor

Corey S. Cutler, MD, MPH, FRCPC

Medical Oncology

 Make an Appointment
Watch Video

Corey S. Cutler, MD, MPH, FRCPC

Physician

  • Medical Director, Adult Stem Cell Transplantation Program
  • Director of Clinical Research, Stem Cell Transplantation
  • Director, Stem Cell Transplantation Survivorship Program
  • Institute Physician
  • Associate Professor of Medicine, Harvard Medical School

Clinical Interests

  • Leukemias
  • Lymphoma
  • Multiple myeloma
  • Myelodysplasia
  • Stem cell/bone marrow transplant

Diseases Treated

  • Allogeneic Stem Cell Transplant

Contact Information

  • Appointments617-632-5138 (new)
    617-632-3470 (follow-up)
  • Office Phone Number617-632-3470
  • Fax617-632-4422
Make an Appointment

Bio

Dr. Cutler received his MD from McGill University, Montreal, Canada. He subsequently received his MPH from the Harvard school of Public Health. He completed postgraduate training in Internal Medicine at Royal Victoria Hospital, Montreal, followed by a fellowship in Hematology/Oncology at DFCI. In 2002, he joined DFCI, where he currently is a member of the Hematologic Malignancies staff.

Board Certification:

  • Hematology, 2002
  • Internal Medicine, 1999
  • Medical Oncology, 2002

Fellowship:

  • Dana-Farber/Partners CancerCare, Medical Oncology

Residency:

  • Royal Victoria Hospital, Internal Medicine

Medical School:

  • McGill University Faculty of Medicine

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions

Ratings

  • Publications
    2/22/2023

    An ongoing commitment to research and innovation has transformed the lives of thousands of patients

    • Immunotherapy
    • Stem Cell/Bone Marrow Transplant
    • Lymphomas
    • Leukemias
    Publications
    4/8/2022

    Dana-Farber's Role in the Worldwide Effort to End the Most Common Side Effect of Stem Cell Transplant

    • Research
    • Stem Cell/Bone Marrow Transplant, Childhood
    • Stem Cell/Bone Marrow Transplant
    Corey Cutler, MD, MPH, FRCPC
    News Releases
    12/4/2020

    Donor stem cell transplant shown to improve survival in older patients with myelodysplastic syndrome

    • Research
    • Myelodysplastic/Myeloproliferative Diseases
    _
    News Releases
    12/1/2020

    Dana-Farber to present more than 40 research studies at 2020 ASH Annual Meeting

    • Research
    • Myelodysplastic/Myeloproliferative Diseases
    • Multiple Myeloma
    • Lymphomas
    • Leukemias
    • Blood Cancer
Top